Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 21-Mar-14 6:27 PM View:  | Dp Vii Associates Lp 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition | 50,743 | $14.00 | $710,402.00 | (100%) 50.74K to 0 | < 1% |
| 21-Mar-14 1:29 PM View: | Atwood Brian G Director | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition (change in control) | 5,007,070 | $14.00 | $70,099,000.00 | (100%) 5.01M to 0 | < 1% |
| 21-Mar-14 7:02 PM View: | Dp Vi Associates, L.P. 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition | 78,369 | $14.00 | $1,097,170.00 | (100%) 78.37K to 0 | < 1% |
| 21-Mar-14 7:32 PM View: | Domain Associates 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition | 27,500 | $14.00 | $385,000.00 | (100%) 27.5K to 0 | < 1% |
| 21-Mar-14 6:59 PM View: | Blair James C Director 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition Duplicate | 10,442,500 | $14.00 | $146,195,008.00 | (100%) 10.44M to 0 | < 1% |
| 21-Mar-14 1:24 PM View: | Larue William R SVP, CFO, Treas, Asst Sec | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition (change in control) | 5,000 | $14.00 | $70,000.00 | (31%) 16.0K to 11.0K | < 1% |
| 21-Mar-14 1:34 PM View: | Barker Sam L Director | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition (change in control) | 20,000 | $14.00 | $280,000.00 | (100%) 20.0K to 0 | < 1% |
| 21-Mar-14 1:22 PM View: | Byrd Scott A. SVP, Chief Commercial Officer | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition (change in control) | 2,000 | $14.00 | $28,000.00 | (100%) 2.0K to 0 | < 1% |
| 21-Mar-14 6:55 PM View: | Dovey Brian H 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition Duplicate | 10,442,500 | $14.00 | $146,195,008.00 | (100%) 10.44M to 0 | < 1% |
| 21-Mar-14 7:43 PM View: | Treu Jesse I 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition Duplicate | 10,442,500 | $14.00 | $146,195,008.00 | (100%) 10.44M to 0 | < 1% |
| 21-Mar-14 1:28 PM View: | Schroeder Theodore R President, CEO Director | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition (change in control) | 12,664 | $14.00 | $177,296.00 | (4%) 320.16K to 307.5K | < 1% |
| 21-Mar-14 1:24 PM View: | Larue William R SVP, CFO, Treas, Asst Sec | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition (change in control) | 11,000 | $14.00 | $154,000.00 | (100%) 11.0K to 0 | < 1% |
| 21-Mar-14 7:46 PM View: | Kamdar Kim P. 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition Duplicate | 27,500 | $14.00 | $385,000.00 | (100%) 27.5K to 0 | < 1% |
| 21-Mar-14 1:49 PM View: | Twomey Christopher J Director | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition (change in control) | 60,000 | $14.00 | $840,000.00 | (100%) 60.0K to 0 | < 1% |
| 21-Mar-14 1:47 PM View: | Rich Todd W Director | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition (change in control) | 10,000 | $14.00 | $140,000.00 | (100%) 10.0K to 0 | < 1% |
| 21-Mar-14 7:24 PM View: | Domain Partners Vi, L.P. 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition | 7,313,240 | $14.00 | $102,385,000.00 | (100%) 7.31M to 0 | < 1% |
| 21-Mar-14 6:44 PM View: | Schoemaker Kathleen K 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition | 10,442,500 | $14.00 | $146,195,008.00 | (100%) 10.44M to 0 | < 1% |
| 21-Mar-14 7:39 PM View: | Halak Brian K 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition | 3,050,920 | $14.00 | $42,712,900.00 | (100%) 3.05M to 0 | < 1% |
| 21-Mar-14 1:43 PM View: | Frazier Alan D Director 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition (change in control) | 8,613,180 | $14.00 | $120,585,000.00 | (100%) 8.61M to 0 | < 1% |
| 21-Mar-14 1:28 PM View: | Schroeder Theodore R President, CEO Director | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition (change in control) | 307,500 | $14.00 | $4,305,000.00 | (100%) 307.5K to 0 | < 1% |
| 21-Mar-14 1:44 PM View: | Garner Cam L Director | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition (change in control) | 1,027,480 | $14.00 | $14,384,800.00 | (100%) 1.03M to 0 | < 1% |
| 21-Mar-14 7:21 PM View: | Vitullo Nicole 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition Duplicate | 10,442,500 | $14.00 | $146,195,008.00 | (100%) 10.44M to 0 | < 1% |
| 21-Mar-14 6:41 PM View: | Domain Parters Vii L P 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition | 2,972,680 | $14.00 | $41,617,500.00 | (100%) 2.97M to 0 | < 1% |
| 21-Mar-14 1:20 PM View: | Aker Hazel M SVP, GC & Secretary | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition (change in control) | 3,745 | $14.00 | $52,430.00 | (100%) 3.75K to 0 | < 1% |
| 21-Mar-14 1:26 PM View: | Lloyd-Smith Malcolm SVP, Reg Affairs, Qual & Clin | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition (change in control) | 2,332 | $14.00 | $32,648.00 | (100%) 2.33K to 0 | < 1% |
| 21-Feb-14 5:11 PM View: | Frazier Alan D Director 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 12-Feb-14 | Payment of Exercise | 973,237 | $14.00 | $13,625,300.00 | (10%) 9.59M to 8.61M | < 1% |
| 14-Feb-14 5:05 PM View: | Domain Parters Vii L P 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 12-Feb-14 | Payment of Exercise | 765,532 | $14.00 | $10,717,400.00 | (20%) 3.74M to 2.97M | |
| 21-Feb-14 5:11 PM View: | Frazier Alan D Director 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 12-Feb-14 | Option Exercise | 1,737,920 | $7.84 | $13,625,300.00 | 22% 7.85M to 9.59M | |
| 14-Feb-14 5:03 PM View: | Dp Vii Associates Lp 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 12-Feb-14 | Payment of Exercise | 13,058 | $14.00 | $182,812.00 | (20%) 63.8K to 50.74K | |
| 21-Feb-14 5:13 PM View: | Atwood Brian G Director | Cadence Pharmaceuticals Inc. (CADX) | 12-Feb-14 | Payment of Exercise | 389,295 | $14.00 | $5,450,130.00 | (7%) 5.4M to 5.01M | < 1% |
| 14-Feb-14 5:05 PM View: | Domain Parters Vii L P 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 12-Feb-14 | Option Exercise | 1,367,020 | $7.84 | $10,717,400.00 | 58% 2.37M to 3.74M | |
| 14-Feb-14 5:03 PM View: | Dp Vii Associates Lp 10% Owner | Cadence Pharmaceuticals Inc. (CADX) | 12-Feb-14 | Option Exercise | 23,317 | $7.84 | $182,805.00 | 58% 40.48K to 63.8K | |
| 21-Feb-14 5:13 PM View: | Atwood Brian G Director | Cadence Pharmaceuticals Inc. (CADX) | 12-Feb-14 | Option Exercise | 695,168 | $7.84 | $5,450,120.00 | 15% 4.7M to 5.4M | |
| 18-Dec-13 4:25 PM View: | Larue William R SVP, CFO, Treas, Asst Sec | Cadence Pharmaceuticals Inc. (CADX) | 17-Dec-13 | Option Exercise | 8,500 | $3.20 | $27,200.00 | 53% 16.0K to 24.5K | |
| 18-Dec-13 4:25 PM View: | Larue William R SVP, CFO, Treas, Asst Sec | Cadence Pharmaceuticals Inc. (CADX) | 17-Dec-13 | Market Option Sale (Planned) | 8,500 | $9.12 | $77,520.00 | (35%) 24.5K to 16.0K | 2% |
| 18-Dec-13 4:22 PM View: | Aker Hazel M SVP, GC & Secretary | Cadence Pharmaceuticals Inc. (CADX) | 16-Dec-13 | Market Option Sale (Planned) | 13,014 | $8.76 | $114,003.00 | (78%) 16.76K to 3.75K | (2%) |
| 18-Dec-13 4:22 PM View: | Aker Hazel M SVP, GC & Secretary | Cadence Pharmaceuticals Inc. (CADX) | 16-Dec-13 | Option Exercise | 13,014 | $3.51 | $45,679.10 | 348% 3.75K to 16.76K | |
| 03-Dec-13 6:05 PM View: | Byrd Scott A. SVP, Chief Commercial Officer | Cadence Pharmaceuticals Inc. (CADX) | 02-Dec-13 | Option Exercise | 7,812 | $3.51 | $27,420.10 | 391% 2.0K to 9.81K | |
| 03-Dec-13 6:05 PM View: | Byrd Scott A. SVP, Chief Commercial Officer | Cadence Pharmaceuticals Inc. (CADX) | 02-Dec-13 | Market Option Sale (Planned) | 7,812 | $9.16 | $71,557.90 | (80%) 9.81K to 2.0K | (3%) |
| 18-Nov-13 6:42 PM View: | Larue William R SVP, CFO, Treas, Asst Sec | Cadence Pharmaceuticals Inc. (CADX) | 18-Nov-13 | Option Exercise | 9,000 | $3.20 | $28,800.00 | 56% 16.0K to 25.0K | |
| 18-Nov-13 6:42 PM View: | Larue William R SVP, CFO, Treas, Asst Sec | Cadence Pharmaceuticals Inc. (CADX) | 18-Nov-13 | Market Option Sale (Planned) | 9,000 | $7.60 | $68,400.00 | (36%) 25.0K to 16.0K | (4%) |
| 18-Nov-13 6:42 PM View: | Larue William R SVP, CFO, Treas, Asst Sec | Cadence Pharmaceuticals Inc. (CADX) | 15-Nov-13 | Market Option Sale (Planned) | 27,000 | $7.20 | $194,400.00 | (63%) 43.0K to 16.0K | (9%) |
| 18-Nov-13 6:39 PM View: | Byrd Scott A. SVP, Chief Commercial Officer | Cadence Pharmaceuticals Inc. (CADX) | 15-Nov-13 | Option Exercise | 10,416 | $3.51 | $36,560.20 | 521% 2.0K to 12.42K | |
| 18-Nov-13 6:36 PM View: | Aker Hazel M SVP, GC & Secretary | Cadence Pharmaceuticals Inc. (CADX) | 15-Nov-13 | Market Option Sale (Planned) | 52,056 | $7.41 | $385,475.00 | (93%) 55.8K to 3.75K | (6%) |
| 18-Nov-13 6:36 PM View: | Aker Hazel M SVP, GC & Secretary | Cadence Pharmaceuticals Inc. (CADX) | 15-Nov-13 | Option Exercise | 52,056 | $3.51 | $182,717.00 | 1390% 3.75K to 55.8K | |
| 18-Nov-13 6:39 PM View: | Byrd Scott A. SVP, Chief Commercial Officer | Cadence Pharmaceuticals Inc. (CADX) | 15-Nov-13 | Market Option Sale (Planned) | 10,416 | $8.00 | $83,328.00 | (84%) 12.42K to 2.0K | 1% |
| 18-Nov-13 6:42 PM View: | Larue William R SVP, CFO, Treas, Asst Sec | Cadence Pharmaceuticals Inc. (CADX) | 15-Nov-13 | Option Exercise | 27,000 | $3.20 | $86,400.00 | 169% 16.0K to 43.0K | |
| 23-Jul-13 6:59 PM View: | Aker Hazel M SVP, GC & Secretary | Cadence Pharmaceuticals Inc. (CADX) | 22-Jul-13 | Option Exercise | 6,507 | $3.51 | $22,839.60 | 174% 3.75K to 10.25K | |
| 23-Jul-13 7:00 PM View: | Lloyd-Smith Malcolm SVP, Reg Affairs, Qual & Clin | Cadence Pharmaceuticals Inc. (CADX) | 22-Jul-13 | Market Option Sale (Planned) | 14,000 | $7.85 | $109,900.00 | (86%) 16.33K to 2.33K | (< 1%) |
| 23-Jul-13 7:00 PM View: | Lloyd-Smith Malcolm SVP, Reg Affairs, Qual & Clin | Cadence Pharmaceuticals Inc. (CADX) | 22-Jul-13 | Option Exercise | 14,000 | $3.51 | $49,140.00 | 600% 2.33K to 16.33K |
